Curesponse
Business Services · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Building B 2 Oppenheimer Haogen St Fl 14...Phone Number
+972 548991150Website
www.curesponse.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Curesponse
Curesponse is a cancer precision medicine company whose platform, cResponse, accurately and timely predicts a patient's response to cancer treatment. Curesponse is headquartered in Rehovot, Israel.Explore more
Curesponse Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Curesponse your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Curesponse
Check out if Curesponse is spiking on competitors!
Check if Curesponse has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if Curesponse had a recent Job posting/layoffs
Curesponse, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Curesponse has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Curesponse recently announced quarterly report
Product Launch: Get notified when Curesponse launches new products
Recommended Actions
Reach out to Masked Content who joined Curesponse as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Curesponse is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Curesponse is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Curesponse.
Curesponse financials insights
Gather financial insights about Curesponse, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series A
$6M
2021
Unspecified
$8M
Curesponse Tech Stack
A closer look at the technologies used by Curesponse
Curesponse News & Media
Curesponse Presents Positive Preliminary Clinical Results from a Multi-Center UK Study at the AACR Meeting in Orlando, Florida
Curesponse, a commercial-stage precision oncology company, presented preliminary clinical results from a multi-center UK Study at the American As ...Curesponse Announces Clalit Health Services, Largest Israeli HMO, to Provide Commercial Coverage for the cResponse™ test
REHOVOT, Israel, Feb. 22, 2023 /PRNewswire/ -- Curesponse, a commercial stage precision oncology company, maker of the cResponse™ platform, an AI-driven, functional-genomics oncology drug prioritization technology, announces that Clalit HMO has decided to include cResponse in the...Curesponse shows applicability of next generation Immuno-oncology drugs in the pan-cancer cResponse system
REHOVOT, Israel, Dec. 21, 2022 /PRNewswire/ -- A poster presented at the recent ESMO Immuno-Oncology Congress in Geneva demonstrates that the cResponse platform can be applied for the modeling and evaluation of immune modulating drugs in cancer tissue. The cResponse assay maintains the...Rafael and Curesponse to Collaborate on Precision Oncology Platform
Curesponse (www.curesponse.com) and Rafael (https://www.rafael.co.il/) to collaborate on integrating Artificial Intelligence capabilities in prec ...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Curesponse
Sign Up For FreeTo access detailed company insights
Curesponse is a cancer precision medicine company whose platform, cResponse, accurately and timely predicts a patient's response to cancer treatment. Curesponse is headquartered in Rehovot, Israel.... Read More
